alexa Currently Used Markers for CTC Isolation - Advantages, Limitations and Impact on Cancer Prognosis | OMICS International | Abstract
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Currently Used Markers for CTC Isolation - Advantages, Limitations and Impact on Cancer Prognosis

Yicun Man, Qing Wang and Wolfgang Kemmner*

Research Group, Surgical Oncology, Experimental Clinical Research Center, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany

*Corresponding Author:
Wolfgang Kemmner
ECRC at the Max-Delbrueck-Center for Molecular Medicine
Research Group Surgical Oncology
Robert Roessle Str. 10, 13125 Berlin, GERMANY
Tel: 49 030 9406 2506
Fax: 49 030 9406 2846; E-mail: [email protected]

Received Date: September 08, 2011; Accepted Date: November 18, 2011; Published Date: November 19, 2011

Citation: Man Y, Wang Q, Kemmner W (2011) Currently Used Markers for CTC Isolation - Advantages, Limitations and Impact on Cancer Prognosis. J Clinic Experiment Pathol 1:102. doi: 10.4172/2161-0681.1000102

Copyright: © 2011 Man Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top